Clinical Trials List
2021-07-30 - 2025-12-31
Phase III
Recruiting4
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Hao-Yuan Wang Division of Hematology & Oncology
- 陳蓉宣 Division of Radiology
- Sheng-Hsuan Chien Division of Hematology & Oncology
- Po-Shen Ko Division of Hematology & Oncology
- 李函叡 Division of Radiology
- Liang-Tsai Hsiao Division of Hematology & Oncology
- Chia-Jen Liu Division of Hematology & Oncology
- 陳玟均 Division of Hematology & Oncology
- 蔡淳光 Division of Hematology & Oncology
- Jyh-Pyng Gau Division of Hematology & Oncology
- Ting-An Lin Division of Hematology & Oncology
- 吳嘉紘 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳宇欽 Division of Hematology & Oncology
- 葉人華 Division of Hematology & Oncology
- 何景良 Division of Hematology & Oncology
- 陳佳宏 Division of Hematology & Oncology
- 戴明燊 Division of Hematology & Oncology
- 黃子權 Division of Hematology & Oncology
- 張平穎 Division of Hematology & Oncology
- 賴學緯 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ming-Yu Lien Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
- Ching-Chan Lin Division of Hematology & Oncology
- Ming-Hung Tsai Division of Hematology & Oncology
- Yu-Min Liao Division of Hematology & Oncology
- Tzu-Ting Chen Division of Hematology & Oncology
- 王秀慈 Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
- 鄭富銘 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 王元欽 Division of Hematology & Oncology
- Hung Chang Division of Hematology & Oncology
- Ming-Chung Kao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
250 participants